Annual International Primary CNS Lymphoma Collaborative Group Meeting

描述（由申请人提供）：原发性中枢神经系统淋巴瘤（PCNSL）是一种局限于神经系统的非霍奇金淋巴瘤（NHL）的结外变异。PCNSL的诊断和治疗方法不同于应用于其他形式的NHL或其他脑癌的方法。国际原发性中枢神经系统淋巴瘤合作小组（IPCG）由来自多个国家和学科的专家组成，致力于PCNSL的研究。IPCG每年在美国血液学学会召开一次科学会议，讨论与PCNSL相关的各种研究课题。每年由一个执行委员会选出一名有关所讨论主题的国际专家来主持科学会议。这些会议导致了多个合作项目，这些项目对该领域产生了积极的影响，并已在同行评议的文献中发表。IPCG年度会议是为这一独特形式的脑癌和淋巴瘤提供新思路和新方法的重要论坛。2014年会议的主题是用于临床实践和临床试验的原发性中枢神经系统淋巴瘤的IPCG评估和反应标准。

DESCRIPTION (provided by applicant): Primary central nervous system lymphoma (PCNSL) is an extranodal variant of non-Hodgkin lymphoma (NHL) that is confined to the nervous system. The diagnostic and therapeutic approaches to PCNSL are different from those that are applied to other forms of NHL or to other brain cancers. The International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) consists of specialists from multiple countries and disciplines dedicated to the study of PCNSL. The IPCG holds an annual scientific conference at the American Society of Hematology meeting in which various research topics related to PCNSL are discussed. An international expert on the topic under discussion is selected each year by an executive committee to chair the scientific conference. These meetings have led to multiple collaborative projects that have positively impacted the field and that have been published in the peer- reviewed literature. The annual IPCG meeting is a critical forum for generating new ideas and approaches to this unique form of brain cancer and lymphoma. The 2014 conference topic is IPCG Evaluation and Response Criteria for Primary CNS Lymphoma for use in clinical practice and in clinical trials.